Cargando…
Critical Review of Plant-Derived Compounds as Possible Inhibitors of SARS-CoV-2 Proteases: A Comparison with Experimentally Validated Molecules
[Image: see text] Ever since coronavirus disease 2019 (COVID-19), caused by SARS-CoV-2, was declared a pandemic on March 11, 2020, by the WHO, a concerted effort has been made to find compounds capable of acting on the virus and preventing its replication. In this context, researchers have refocused...
Autores principales: | Guerra, Yasel, Celi, Diana, Cueva, Paul, Perez-Castillo, Yunierkis, Giampieri, Francesca, Alvarez-Suarez, José Miguel, Tejera, Eduardo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2022
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9753184/ https://www.ncbi.nlm.nih.gov/pubmed/36530229 http://dx.doi.org/10.1021/acsomega.2c05766 |
Ejemplares similares
-
Drugs Repurposing Using QSAR, Docking and Molecular Dynamics for Possible Inhibitors of the SARS-CoV-2 M(pro) Protease
por: Tejera, Eduardo, et al.
Publicado: (2020) -
Computational modeling predicts potential effects of the herbal infusion “horchata” against COVID-19
por: Tejera, Eduardo, et al.
Publicado: (2022) -
Cinnamomum sp. and Pelargonium odoratissimum as the Main Contributors to the Antibacterial Activity of the Medicinal Drink Horchata: A Study Based on the Antibacterial and Chemical Analysis of 21 Plants
por: Fernandez-Soto, Paulina, et al.
Publicado: (2023) -
The dilemma of bacterial expansins evolution. The unusual case of Streptomyces acidiscabies and Kutzneria sp. 744
por: Armijos-Jaramillo, Vinicio, et al.
Publicado: (2018) -
Nutraceutical Compounds Targeting Inflammasomes in Human Diseases
por: Castejón-Vega, Beatriz, et al.
Publicado: (2020)